Access the full text.
Sign up today, get DeepDyve free for 14 days.
Xiao-guang Liu, Wang-Yu Zhu, Yanyan Huang, Li-na Ma, Shi-quan Zhou, Ye-kai Wang, Fang Zeng, Ji-hang Zhou, Yongkui Zhang (2012)
High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancerMedical Oncology, 29
Can Liu, K. Kelnar, A. Vlassov, D. Brown, Junchen Wang, D. Tang (2012)
Distinct microRNA expression profiles in prostate cancer stem/progenitor cells and tumor-suppressive functions of let-7.Cancer research, 72 13
P. Mitchell, R. Parkin, E. Kroh, B. Fritz, S. Wyman, E. Pogosova-Agadjanyan, Amelia Peterson, J. Noteboom, K. O'Briant, A. Allen, D. Lin, N. Urban, C. Drescher, B. Knudsen, Derek Stirewalt, R. Gentleman, R. Vessella, P. Nelson, Daniel Martin, M. Tewari (2008)
Circulating microRNAs as stable blood-based markers for cancer detectionProceedings of the National Academy of Sciences, 105
J. Hayes, Pierpaolo Peruzzi, S. Lawler (2014)
MicroRNAs in cancer: biomarkers, functions and therapy.Trends in molecular medicine, 20 8
Lijian Xu, Qiang Li, Dong Xu, Qingguang Wang, Yong An, Qing Du, Jing-Jing Zhang, Yi Zhu, Y. Miao (2014)
hsa-miR-141 downregulates TM4SF1 to inhibit pancreatic cancer cell invasion and migration.International journal of oncology, 44 2
B. Mateescu, L. Batista, M. Cardon, T. Gruosso, Y. Feraudy, O. Mariani, A. Nicolas, J. Meyniel, P. Cottu, X. Sastre-Garau, F. Mechta-Grigoriou (2011)
miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress responseNature Medicine, 17
D. Taylor, Ç. Gerçel-Taylor (2008)
MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer.Gynecologic oncology, 110 1
A. Pasquinelli (2012)
MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationshipNature Reviews Genetics, 13
D. Bartel (2009)
MicroRNAs: Target Recognition and Regulatory FunctionsCell, 136
V. Guire, R. Robitaille, N. Tétreault, R. Guérin, Catherine Ménard, N. Bambace, P. Sapieha (2013)
Circulating miRNAs as sensitive and specific biomarkers for the diagnosis and monitoring of human diseases: promises and challenges.Clinical biochemistry, 46 10-11
(2014)
A home-brew realtime PCR assay for reliable detection and quantification of mature miR-122. AppI Immunohistochem Mol Morphol
M. Jaarsveld, J. Helleman, A. Boersma, P. Kuijk, W. Ijcken, E. Despierre, I. Vergote, R. Mathijssen, E. Berns, J. Verweij, J. Pothof, E. Wiemer (2013)
miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cellsOncogene, 32
Jason Gonzales, L. Fink, O. Goodman, J. Symanowski, N. Vogelzang, D. Ward (2011)
Comparison of circulating MicroRNA 141 to circulating tumor cells, lactate dehydrogenase, and prostate-specific antigen for determining treatment response in patients with metastatic prostate cancer.Clinical genitourinary cancer, 9 1
Jun Xue, Y. Niu, Jing Huang, G. Peng, Li-xia Wang, Yu-hui Yang, Yun-qiao Li (2014)
miR-141 suppresses the growth and metastasis of HCC cells by targeting E2F3Tumor Biology, 35
J. Brase, Marc Johannes, T. Schlomm, Maria Fälth, A. Haese*, T. Steuber, T. Beissbarth, R. Kuner, H. Sültmann (2011)
Circulating miRNAs are correlated with tumor progression in prostate cancerInternational Journal of Cancer, 128
X. Chen, Xuegang Wang, A. Ruan, Weiwei Han, Yan Zhao, Xing-Sui Lu, Pei Xiao, Hang-chuan Shi, Rong Wang, Li Chen, Shaoyong Chen, Q. Du, Hongmei Yang, Xiaoping Zhang (2014)
miR-141 Is a Key Regulator of Renal Cell Carcinoma Proliferation and Metastasis by Controlling EphA2 ExpressionClinical Cancer Research, 20
M. Naderi, M. Paryan, K. Azadmanesh, H. Rafatpanah, H. Rezvan, S. Samiee (2012)
Design and development of a quantitative real time PCR assay for monitoring of HTLV-1 provirus in whole blood.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 53 4
Samira Mohammadi-Yeganeh, M. Paryan, S. Samiee, M. Soleimani, E. Arefian, K. Azadmanesh, E. Mostafavi, R. Mahdian, M. Karimipoor (2013)
Development of a robust, low cost stem-loop real-time quantification PCR technique for miRNA expression analysisMolecular Biology Reports, 40
R. Bryant, T. Pawlowski, J. Catto, G. Marsden, R. Vessella, B. Rhees, C. Kuslich, T. Visakorpi, F. Hamdy (2012)
Changes in circulating microRNA levels associated with prostate cancerBritish Journal of Cancer, 106
Bitao Chen, Tao Huang, Jun Jiang, L. Lv, Hongxing Li, Shitao Xia (2014)
miR-141 suppresses proliferation and motility of gastric cancer cells by targeting HDGFMolecular and Cellular Biochemistry, 388
Han Nguyen, W. Xie, Ming Yang, C. Hsieh, S. Drouin, G. Lee, P. Kantoff (2013)
Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low‐risk, localized prostate cancerThe Prostate, 73
Hanyin Cheng, Lina Zhang, D. Cogdell, Hong Zheng, Aaron Schetter, M. Nykter, C. Harris, Kexin Chen, S. Hamilton, Wei Zhang (2011)
Circulating Plasma MiR-141 Is a Novel Biomarker for Metastatic Colon Cancer and Predicts Poor PrognosisPLoS ONE, 6
Jin Wang, Kejian Zhang, Song-Mei Liu, S. Sen (2014)
Tumor-Associated Circulating MicroRNAs as Biomarkers of CancerMolecules, 19
Ying Liu, Yi Ding, Jing Huang, Shuang Wang, Wen Ni, J. Guan, Qi-sheng Li, Yuqin Zhang, Yan Ding, Bin Chen, Longhua Chen (2014)
MiR-141 Suppresses the Migration and Invasion of HCC Cells by Targeting Tiam1PLoS ONE, 9
Gang Zhao, Bo Wang, Yang Liu, Jun-gang Zhang, Shi-chang Deng, Qi Qin, Kui Tian, Xiang Li, Shuai Zhu, Y. Niu, Qiong Gong, Chun-you Wang (2013)
miRNA-141, Downregulated in Pancreatic Cancer, Inhibits Cell Proliferation and Invasion by Directly Targeting MAP4K4Molecular Cancer Therapeutics, 12
M. Naderi, Hossein Tehrani, M. Soleimani, I. Shabani, Seyed Hashemi (2015)
A Home-brew Real-time PCR Assay for Reliable Detection and Quantification of Mature miR-122Applied Immunohistochemistry & Molecular Morphology, 23
L. Selth, S. Townley, Joanna Gillis, Aleksandra Ochnik, K. Murti, R. Macfarlane, K. Chi, V. Marshall, W. Tilley, L. Butler (2012)
Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of diseaseInternational Journal of Cancer, 131
Ying Du, Yanjun Xu, L. Ding, H. Yao, Hong-wei Yu, Tianhua Zhou, Jianmin Si (2009)
Down-regulation of miR-141 in gastric cancer and its involvement in cell growthJournal of Gastroenterology, 44
G. Cheng (2015)
Circulating miRNAs: roles in cancer diagnosis, prognosis and therapy.Advanced drug delivery reviews, 81
Liu (2012)
. High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer.Med Ocol, 29
Xiuyue Yu, Zhe Zhang, Jiao Liu, Bo Zhan, C. Kong (2013)
MicroRNA-141 is downregulated in human renal cell carcinoma and regulates cell survival by targeting CDC25BOncoTargets and therapy, 6
RESEARCH ARTICLE Reproducible and Reliable Real-time PCR Assay to Measure Mature Form of miR-141 Seyed Hamid Aghaee-Bakhtiari,* Ehsan Arefian, PhD,w Masoud Soleimani, PhD,z Farshid Noorbakhsh, PhD,y Siamak Mirab Samiee, PhD,8 Pezhman Fard-Esfahani, PhD,z and Reza Mahdian, PhD* Key Words: mir-141, real time PCR, prostate cancer, ovarian Abstract: miR-141 is one of the miRNAs that has significant cancer, colon cancer expression variations in different human malignancies including (Appl Immunohistochem Mol Morphol 2015;00:000–000) prostate cancer, hepatocellular carcinoma, renal cell carcinoma, pancreatic cancer, gastric cancer, and ovarian cancer. Fur- thermore, various studies have designated miR-141 as a prog- nostic and diagnostic biomarker in different types of cancer. iRNAs are small endogenous noncoding RNAs that Thus, accurate and precise quantification of miR-141 is very mplay a key role in controlling gene expression essential for clinical diagnostics. In this regard, development of a through binding to their target sites on the 3 UTR of reproducible and reliable assay for miR-141 can be the first step mRNAs. Several studies showed the significant role of to standardize quantification of this valuable biomarker for miRNAs in a broad range of biological activities and in vitro diagnostics assays. Using stem-loop approach, we de- their regulatory functions in varieties
Applied Immunohistochemistry & Molecular Morphology – Wolters Kluwer Health
Published: Mar 1, 2015
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.